Header Logo

Connection

MARGARET SPITZ to Neoplasms

Back to Details
This is a "connection" page, showing publications MARGARET SPITZ has written about Neoplasms.
MARGARET SPITZ
Connection Strength
2.101
Neoplasms
  1. The authors reply. Am J Epidemiol. 2015 Mar 01; 181(5):361.
    View in: PubMed
    Score: 0.170
  2. The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol. 2014 Nov 15; 180(10):964-7.
    View in: PubMed
    Score: 0.165
  3. Integrative cancer epidemiology--the next generation. Cancer Discov. 2012 Dec; 2(12):1087-90.
    View in: PubMed
    Score: 0.145
  4. 'Confounding' our future. Cancer Epidemiol Biomarkers Prev. 2011 Apr; 20(4):578-9.
    View in: PubMed
    Score: 0.129
  5. The evolving discipline of molecular epidemiology of cancer. Carcinogenesis. 2010 Jan; 31(1):127-34.
    View in: PubMed
    Score: 0.118
  6. Aggregation of cancer among relatives of never-smoking lung cancer patients. Int J Cancer. 2007 Jul 01; 121(1):111-8.
    View in: PubMed
    Score: 0.100
  7. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res. 2007 Apr 15; 67(8):3493-5.
    View in: PubMed
    Score: 0.098
  8. Re: "Cancer mortality among US men and women with asthma and hay fever". Am J Epidemiol. 2006 Feb 15; 163(4):394-5; author reply 395-6.
    View in: PubMed
    Score: 0.090
  9. Integrative epidemiology: from risk assessment to outcome prediction. J Clin Oncol. 2005 Jan 10; 23(2):267-75.
    View in: PubMed
    Score: 0.084
  10. Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):963-9.
    View in: PubMed
    Score: 0.077
  11. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8.
    View in: PubMed
    Score: 0.076
  12. Improving residents' knowledge of cancer prevention: are physicians prepared for prevention? J Cancer Educ. 1995; 10(1):9-13.
    View in: PubMed
    Score: 0.042
  13. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.041
  14. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1729-51.
    View in: PubMed
    Score: 0.040
  15. Mutagen sensitivity as a marker of cancer risk. Cancer Detect Prev. 1994; 18(4):299-303.
    View in: PubMed
    Score: 0.039
  16. Cancer risk and early detection assessment. Semin Oncol Nurs. 1993 Aug; 9(3):188-97.
    View in: PubMed
    Score: 0.038
  17. Genetic susceptibility to cancer. Cancer. 1993 Aug 01; 72(3 Suppl):991-5.
    View in: PubMed
    Score: 0.038
  18. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):508-16.
    View in: PubMed
    Score: 0.037
  19. "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):181-8.
    View in: PubMed
    Score: 0.037
  20. AACR Cancer Progress Report 2012. Clin Cancer Res. 2012 Nov 01; 18(21 Suppl):S1-100.
    View in: PubMed
    Score: 0.036
  21. Cancer prevention practices among Texas primary care physicians. J Cancer Educ. 1992; 7(1):55-60.
    View in: PubMed
    Score: 0.034
  22. p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature. Mutagenesis. 2012 May; 27(3):267-73.
    View in: PubMed
    Score: 0.034
  23. Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. PLoS One. 2010 May 28; 5(5):e10858.
    View in: PubMed
    Score: 0.031
  24. Early cancer detection: update for primary-care physicians. Tex Med. 1990 Apr; 86(4):44-7.
    View in: PubMed
    Score: 0.030
  25. Cigarette smoking patterns of cancer patients. Prog Clin Biol Res. 1990; 339:73-82.
    View in: PubMed
    Score: 0.030
  26. The implementation and applications of a cancer patient risk evaluation questionnaire. Prog Clin Biol Res. 1989; 293:263-70.
    View in: PubMed
    Score: 0.028
  27. Sociodemographic characteristics, health beliefs, and the accuracy of cancer knowledge. J Cancer Educ. 2009; 24(1):58-64.
    View in: PubMed
    Score: 0.028
  28. The development of a comprehensive, institution-based patient risk evaluation program: I. Development, content, and data management. Am J Prev Med. 1988 Jul-Aug; 4(4):183-7.
    View in: PubMed
    Score: 0.027
  29. The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. Am J Prev Med. 1988 Jul-Aug; 4(4):188-93.
    View in: PubMed
    Score: 0.027
  30. Profiles of cigarette smoking among patients in a cancer center. J Cancer Educ. 1988; 3(4):265-71.
    View in: PubMed
    Score: 0.026
  31. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007 Dec 06; 450(7171):893-8.
    View in: PubMed
    Score: 0.026
  32. Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res. 2006 Jun 15; 66(12):5993-6.
    View in: PubMed
    Score: 0.023
  33. The biology of tobacco and nicotine: bench to bedside. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):764-7.
    View in: PubMed
    Score: 0.021
  34. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res. 2004 Mar 15; 64(6):2251-7.
    View in: PubMed
    Score: 0.020
  35. Development of common data elements: the experience of and recommendations from the early detection research network. Int J Med Inform. 2003 Apr; 70(1):41-8.
    View in: PubMed
    Score: 0.019
  36. Genetic instability of specific chromosomes associated with a family history of cancer. Cancer Genet Cytogenet. 2002 Jul 01; 136(1):73-7.
    View in: PubMed
    Score: 0.018
  37. Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. J Clin Oncol. 2000 Nov 01; 18(21 Suppl):9S-18S.
    View in: PubMed
    Score: 0.016
  38. Three measures of mutagen sensitivity in a cancer-free population. Cancer Genet Cytogenet. 1999 Apr; 110(1):65-9.
    View in: PubMed
    Score: 0.014
  39. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 05; 96(3):487-97.
    View in: PubMed
    Score: 0.011
  40. IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect. 2015 Jun; 123(6):507-14.
    View in: PubMed
    Score: 0.011
  41. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012 May 06; 44(6):651-8.
    View in: PubMed
    Score: 0.009
  42. Cancer and age. Semin Oncol. 1989 Feb; 16(1):3-9.
    View in: PubMed
    Score: 0.007
  43. Epidemiologic similarities leading to etiologic hypotheses. Princess Takamatsu Symp. 1987; 18:173-80.
    View in: PubMed
    Score: 0.006
  44. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis. 2002 Feb; 23(2):295-9.
    View in: PubMed
    Score: 0.004
  45. Development of a database for assessing dietary phytoestrogen intake. Nutr Cancer. 1999; 33(1):3-19.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.